2018-11-01T09:32:58-05:00 2017-12-31 541149263 YOUNT HYDE & BARBOUR PC PO BOX 2560 WINCHESTER VA 226041760 990 2017-01-01 131772100 NATIONAL PHARMACEUTICAL COUNCIL INC NATI 2028272100 1717 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 20006 KATHRYN GLEASON VICE PRESIDENT 2028272100 2018-10-29 1 OLIVIA A HUTTON CPA P00964688 5406623417 2018-10-25 64.4.100.170 2018-10-29 11:58:41 ED P 2BD9941C2218514039E2696DAFBBB0AADD46666A 2BD9941C2218514039E2696DAFBBB0AADD46666A 2017 2019-02-21 02:37:17Z KATHRYN GLEASON 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 23553931 0 X SEE SCHEDULE O X 1953 NY THE NATIONAL PHARMACEUTICAL COUNCIL (NPC) FOCUSES ON RESEARCH AND DEVELOPMENT, INFORMATION DISSEMINATION, EDUCATION AND COMMUNICATION OF THE CRITICAL ISSUES OF EVIDENCE, INNOVATION AND THE VALUE OF MEDICINES FOR PATIENTS. 21 21 14 0 0 0 0 0 8292500 8700000 220710 791373 0 0 8513210 9491373 0 0 0 0 4129152 3027493 0 0 0 4707052 5520834 8836204 8548327 -322994 943046 18779988 17504629 6692069 4280535 12087919 13224094 TO SPONSOR, PARTICIPATE IN AND PROMOTE THE SCIENTIFIC ANALYSES OF THE APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMIC VALUE OF IMPROVED HEALTH OUTCOMES THROUGH PHARMACEUTICAL INNOVATION. 0 0 THE NATIONAL PHARMACEUTICAL COUNCIL SPONSORS AND CONDUCTS SCIENTIFIC ANALYSES OF THE APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMIC VALUE OF INNOVATION. THE ORGANIZATION'S STRATEGIC FOCUS IS ON EVIDENCE-BASED MEDICINE (EBM) FOR HEALTH CARE DECISION-MAKING TO ENSURE THAT PATIENTS HAVE ACCESS TO HIGH-QUALITY CARE. ALL ACTIVITIES UNDERTAKEN BY THE COUNCIL RELATE TO THESE FUNCTIONS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 18 0 1 14 1 0 0 0 0 1 1 0 X 21 21 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X NATIONAL PHARMACEUTICAL COUNCIL 2028272100 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 DANIEL LEONARD PRESIDENT 40.00 X X 1249783 0 38513 ROBERT DUBOIS VICE PRESIDENT 40.00 X X 515653 0 36909 RICHARD BAGGER TREASURER 1.00 X 0 0 0 JOSHUA OFMAN CHAIRMAN 1.00 X 0 0 0 MARK NAGY VICE CHAIRMAN 1.00 X 0 0 0 PATRICK MAGRI IMMEDIATE PAST CHAIR 1.00 X 0 0 0 MICHAEL RYAN DIRECTOR 1.00 X 0 0 0 MIKE STAFF DIRECTOR 1.00 X 0 0 0 JAN HANSEN DIRECTOR 1.00 X 0 0 0 DAVID MACARIOS DIRECTOR 1.00 X 0 0 0 SHONTELLE DODSON DIRECTOR 1.00 X 0 0 0 DON SAWYER DIRECTOR 1.00 X 0 0 0 CHRISTINE MARSH DIRECTOR 1.00 X 0 0 0 JENNIFER NORTON DIRECTOR 1.00 X 0 0 0 DAVID COX DIRECTOR 1.00 X 0 0 0 BLASINE PENKOWSKI DIRECTOR 1.00 X 0 0 0 STEVEN ROMANO DIRECTOR 1.00 X 0 0 0 ROBERT SPURR DIRECTOR 1.00 X 0 0 0 TRACY MAYNE DIRECTOR 1.00 X 0 0 0 DARRYL SLEEP DIRECTOR 1.00 X 0 0 0 ANDY SCHMELTZ DIRECTOR 1.00 X 0 0 0 KYLE HVIDSTEN DIRECTOR 1.00 X 0 0 0 GEORGE KEEFE DIRECTOR 1.00 X 0 0 0 KATHRYN GLEASON SENIOR VP 40.00 X X 217012 0 19314 JENNIFER GRAFF VP, CER 40.00 X 250088 0 28253 ANDREA HOFELICH VP, COMMUNICATIONS 40.00 X 214823 0 31970 KIMBERLY WESTRICH VP, HEALTH SERVICES RESEAR 40.00 X 251222 0 31013 MICHAEL CIARAMENTARO VP, RESEARCH 40.00 X 221162 0 27105 2919743 0 213077 7 0 1 0 HEALTH AFFAIRS 7500 OLD GEORGETOWN ROAD SUITE 600 BETHESDA MD 20814 RESEARCH 807000 RTI HEALTH SOLUTIONS PO BOX 14668 RESEARCH TRIANGLE PARK NC 27709 RESEARCH 358220 PRECISION HEALTH ECONOMICS LLC PO BOX 75727 BALTIMORE MD 21275 RESEARCH 268214 JONES PUBLIC AFFAIRS 1420K STREET NW STE 1050 WASHINGTON DC 20005 PR AGENCY 199704 ANALYSIS GROUP INC 800 WASHINGTON ST BOX 453 BOSTON MA 02111 RESEARCH 170630 5 MEMBERSHIP DUES 900099 8700000 8700000 8700000 297786 297786 14556145 14062558 493587 493587 493587 9491373 8700000 0 791373 2884552 719431 24253 -747758 147015 96009 69982 35537 638053 121571 196752 334484 76594 122545 93 70415 25277 PROGRAMS, SPECIAL STUDI 3657972 SUBSCRIPTIONS & MEMBERS 69446 ENTERTAINMENT 5671 OTHER 433 8548327 3332721 2695403 621036 601398 260050 275975 682822 424136 323043 258686 14175138 13651167 68000 22000 18779988 17504629 742492 827123 2275000 950000 3674577 2503412 6692069 4280535 X 12086834 13224094 1085 0 12087919 13224094 18779988 17504629 943046 193129 0 X X 0 1 X 1 0 1 1 0 376040 206822 169218 204760 182215 22545 102022 35099 66923 258686 PENSION COST LIABILITY 710069 NONQUALIFIED, DEFERRED COMPENSATION LIABILITY 1606810 DEFERRED LEASE INCENTIVE, NET 186533 2503412 9684502 193129 193129 9491373 0 9491373 8548327 0 8548327 0 8548327 PART XI, LINE 4B - OTHER ADJUSTMENTS: LOSS ON DISPOSAL PART XII, LINE 2D - OTHER ADJUSTMENTS: LOSS ON DISPOSAL X 1 1 X X X 0 1 0 DANIEL LEONARD PRESIDENT 679117 0 301977 0 268689 0 13500 0 25013 0 1288296 0 0 0 ROBERT DUBOIS VICE PRESIDENT 429116 0 50923 0 35614 0 13500 0 23409 0 552562 0 0 0 KATHRYN GLEASON SENIOR VP 195009 0 21630 0 373 0 9283 0 10031 0 236326 0 0 0 JENNIFER GRAFF VP, CER 227764 0 21622 0 702 0 11027 0 17226 0 278341 0 0 0 ANDREA HOFELICH VP, COMMUNICATIONS 192383 0 21630 0 810 0 9193 0 22777 0 246793 0 0 0 KIMBERLY WESTRICH VP, HEALTH SERVICES RESEAR 225032 0 25947 0 243 0 11207 0 19806 0 282235 0 0 0 MICHAEL CIARAMENTARO VP, RESEARCH 199246 0 21754 0 162 0 7500 0 19605 0 248267 0 0 0 PART I, LINE 1A DANIEL LEONARD RECEIVES GROSS-UP PAYMENTS TO THE NONQUAILIFIED RETIREMENT PLAN AVAILABLE TO OFFICERS. THESE PAYMENTS ARE INCLUDED IN THEIR TAXABLE COMPENSATION WHEN PAID. PART I, LINE 4B SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN - DANIEL LEONARD - $256,489 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE TREASURER AND THE VICE PRESIDENT OF MEMBERSHIP AND OPERATIONS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY COVERS ALL MEMBERS OF THE BOARD, THE OFFICERS, AND STAFF AND IS MONITORED BY ANNUAL WRITTEN INFORMATION QUESTIONNAIRES FROM THE PRESIDENT WHICH ARE REVIEWED AND MAINTAINED BY THE VICE PRESIDENT OF BUSINESS OPERATIONS AND EXTERNAL AFFAIRS. THE BOARD OFFICERS REVIEW EACH TRANSACTION TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF ANY POTENTIAL OR ACTUAL CONFLICTS ARE IDENTIFIED THE PERSON DETERMINED TO HAVE A CONFLICT IS RECUSED FROM DELIBERATIONS, VOTING OR ANY ACTIONS RELATED TO THE MATTER. THE IDENTIFIED CONFLICTS WOULD BE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS FOR DETERMINING COMPENSATION INCLUDES A REVIEW AND APPROVAL BY THE CHAIRMAN OF BOARD, WHO IS AN INDEPENDENT BOARD MEMBER ELECTED ANNUALLY ON A ROTATING BASIS. COMPARABILITY DATA USED IN THE REVIEW PROCESS IS OBTAINED FROM PUBLIC SOURCES, RECRUITERS, AND OTHER HUMAN RESOURCE PROFESSIONALS. THE AUDIT AND BUDGET COMMITTEE APPROVES TOTAL SALARIES AS APPROVED BY THE CHAIRMAN. THE COMPENSATION DETERMINATION PROCESS APPLIES TO THE MOST RECENT YEAR FOR WHICH THE PROCESS WAS UNDERTAKEN. THE CHAIRMAN OF THE BOARD REVIEWS AND APPROVES THE SALARY FOR THE PRESIDENT. THE PRESIDENT REVIEWS AND APPROVES ALL OTHERS WITHIN THE BUDGET, WHICH ARE ALSO APPROVED BY THE AUDIT AND BUDGET COMMITTEES. ALL SALARIES WERE REVIEWED AND APPROVED IN 2017. FORM 990, PART VI, SECTION C, LINE 19 THE NATIONAL PHARMACEUTICAL COUNCIL DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART XII, LINE 2C: PROCESS HAS NOT CHANGED.